Biosynex SA (EPA:ALBIO)
France · Delayed Price · Currency is EUR 0.9100
0.00 (0.00%)
Aug 12, 2026, 9:51 AM CET
Biosynex Market Cap
Biosynex has a market cap or net worth of €16.77 million as of August 11, 2026. Its market cap has decreased by -25.45% in one year.
Market Cap
16.77M
Enterprise Value
69.96M
Revenue
95.19M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.91
ChartMarket Cap Chart
Since March 25, 2011, Biosynex's market cap has increased from 8.12M to 16.77M, an increase of 106.50%. That is a compound annual growth rate of 4.82%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2026 | 16.77M | 50.11% |
| Dec 31, 2025 | 11.17M | -39.63% |
| Dec 31, 2024 | 18.51M | -78.44% |
| Dec 29, 2023 | 85.85M | -39.13% |
| Dec 30, 2022 | 141.04M | -51.35% |
| Dec 31, 2021 | 289.89M | 91.16% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eurobio Scientific Société anonyme | 216.47M |
| Median Technologies | 158.96M |
| Guerbet | 104.71M |
| Theraclion | 44.16M |
| Novacyt | 31.90M |
| Mauna Kea Technologies | 29.20M |
| Diagnostic Medical Systems | 28.25M |
| Implanet | 25.71M |